SCHEMBL5175157

SCHEMBL5175157

CN(C)C(=O)Oc1ccc(OCCN2CCC(O)(c3ccccc3)CC2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.56
▸ LMNA P02545 3/20 0.56
▸ KMT2A Q03164 3/20 0.56
▸ ALDH1A1 P00352 1/20 0.56
▸ LTA4H P09960 3/20 0.53
▸ DRD2 P14416 4/20 0.47
▸ SLC6A4 P31645 3/20 0.46
▸ HTR2B P41595 3/20 0.46
▸ DRD3 P35462 3/20 0.46
▸ SIGMAR1 Q99720 3/20 0.46
▸ HTR1A P08908 2/20 0.46
▸ DRD1 P21728 2/20 0.46
▸ SLC6A2 P23975 2/20 0.46
▸ ADRB2 P07550 2/20 0.46
▸ ADRA2A P08913 2/20 0.46
▸ DRD4 P21917 2/20 0.46
▸ OPRM1 P35372 2/20 0.46
▸ OPRD1 P41143 2/20 0.46
▸ OPRK1 P41145 2/20 0.46
▸ SLC6A3 Q01959 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5175696 0.90 ALDH1A1 (0.53) MEN1LMNAKMT2AALDH1A1LTA4H
SCHEMBL5175324 0.81 KCNA5 (0.54) MEN1LMNAKMT2AALDH1A1LTA4H
SCHEMBL4688810 0.81 MEN1 (0.62) MEN1LMNAKMT2AALDH1A1LTA4H
SCHEMBL5174031 0.81 MEN1 (0.57) MEN1LMNAKMT2AALDH1A1LTA4H
Hydrochloric Acid SCHEMBL7406712 0.80 MEN1 (0.61) MEN1LMNAKMT2AALDH1A1LTA4H
SCHEMBL5175644 0.79 MEN1 (0.58) MEN1LMNAKMT2AALDH1A1LTA4H
SCHEMBL5175935 0.78 ALDH1A1 (0.51) MEN1LMNAKMT2AALDH1A1LTA4H
SCHEMBL11717047 0.77 ALDH1A1 (0.74) MEN1LMNAKMT2AALDH1A1LTA4H
SCHEMBL5174629 0.76 MEN1 (0.57) MEN1LMNAKMT2AALDH1A1DRD2
SCHEMBL5174431 0.76 MET (0.47) MEN1LMNAKMT2AALDH1A1LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1868605-A2 PHENYL AND PYRIDYL LTA4H MODULATORS Janssen Pharmaceutica, N.V. (BE) 2007-12-26 — — EP claimed
WO-2006105304-A2 PHENYL AND PYRIDYL LTA4H MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2006-10-05 — — WO claimed
US-20060223792-A1 Phenyl and pyridyl LTA4H modulators JANSSEN PHARMACEUTICA N.V. (BE) 2006-10-05 — — US claimed
EP-1868605-A2 PHENYL AND PYRIDYL LTA4H MODULATORS Janssen Pharmaceutica, N.V. (BE) 2007-12-26 — — EP disclosed
WO-2006105304-A2 PHENYL AND PYRIDYL LTA4H MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2006-10-05 — — WO disclosed
US-20060223792-A1 Phenyl and pyridyl LTA4H modulators JANSSEN PHARMACEUTICA N.V. (BE) 2006-10-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060223792-A1 Phenyl and pyridyl LTA4H modulators LTA4H, LTB4R, LTC4S MEN1 4858/4885LMNA 2091/4885KMT2A 3196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback